< Back to companies

Preeclampsia is one of the leading causes of maternal and fetal morbidity and mortality. Prediction of preeclampsia-related adverse events is an unmet medical need. We have developed a digital plattform for better prediciton and prognosis of the disease in women at high risk for preeclampsia. PreFree consists of a machine-learning algorithmus feeding into a decision-support tool for ObGyns and remote monitoring App for patients. PreFree will be a class IIa medical device according to MDR, the regulatory approval is under way.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2023
Website
prefree.de/

Categories

Women's HealthPredictive DiagnosticsAI / MLClinical Decision Support
Only accessible to MedStartr community members. Join now

What do you think of PreFree?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now